#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Nephropathy Indolent systemic mastocytosis Familial hypertriglyceridaemia Leukocyte adhesion deficiency type I Oesophageal squamous cell carcinoma stage III Primary adrenal insufficiency Plasma cell myeloma refractory Cardiac failure acute Extranodal marginal zone B-cell lymphoma (MALT type) Severe myoclonic epilepsy of infancy Pulmonary arterial hypertension Gastrooesophageal cancer Retinoblastoma Erdheim-Chester disease Follicle centre lymphoma follicular grade I II – III refractory More trials…

    Learn about Rare Diseases

    Haemophilia B without inhibitors – Diagnostics Breast angiosarcoma – Life with Disease Ehlers-Danlos syndrome – Life with Disease Propionic acidaemia Mantle cell lymphoma stage IV – Treatment Phenylketonuria Immunodeficiency congenital – Trials in Disease MELAS syndrome – Trials in Disease Lymphangioma – Basic Information Aicardi-Goutieres syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Doxribtimine Tominersen Bjt-778 Oseltamivir Mycophenolic Acid IADADEMSTAT Quemliclustat Betula Pendula Pollen Extract Eptacog Beta (Activated) L-Histidine Hydrochloride Tanimilast Mps-200 Peboctocogene Camaparvovec Mosaic Hbcoreag Palbociclib Alfacalcidol Cloxacillin Sodium Cd19-Car_Lenti_Allo Doxecitine Lisinopril Dihydrate More therapies…

    Learn about Your Condition

    Angiosarcoma Bone sarcoma Retroperitoneal fibrosis Trigeminal neuralgia Endocrine ophthalmopathy Laryngeal cancer stage III Endometrial cancer stage I Lung neoplasm malignant Narcolepsy Prinzmetal angina Acute myeloid leukaemia Procedural haemorrhage Insomnia Large cell lung cancer stage 0 Brain stem glioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study on Dexamethasone and Fluorometholone for Patients Undergoing Corneal Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Corneal graft failure
    • Corneal graft rejection
    Investigated Drugs:
    • Fluorometholone
    • Dexamethasone
    Germany The Netherlands

  • Study on Melatonin for Patients with Uveal Melanoma to Prevent Metastasis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Uveal melanoma
    Investigated Drugs:
    • Melatonin
    Sweden

  • Study on the Effectiveness of Citicoline Eye Drops for Visual Field Preservation in Patients with Open Angle Glaucoma

    Recruiting

    3 1
    Investigated Diseases:
    • Exfoliation glaucoma
    • Pigmentary glaucoma
    • Open angle glaucoma
    Investigated Drugs:
    • Citicoline Sodium
    Belgium France Greece Hungary Italy Poland +1

  • Study on Nepafenac and Dexamethasone for Reducing Inflammation and Swelling in Fuchs Dystrophy Patients After Corneal Transplant

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Corneal dystrophy
    Investigated Drugs:
    • Nepafenac
    • Dexamethasone
    Norway

  • Study on the Effectiveness and Safety of Beltavac for Patients with Allergic Rhinitis from House Dust Mites

    Recruiting

    3 1
    Investigated Diseases:
    • Mite allergy
    Investigated Drugs:
    • Mixture Of Allergen Extracts Of Dermatophagoides Pteronyssinus And Dermatophagoides Farinae Polymerized With Glutaraldehyde
    Spain

  • A Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    Investigated Drugs:
    • Aflibercept
    • Fluorescein Sodium
    Austria Croatia Czechia Denmark France Hungary +4
Previous Page
1 … 10 11 12 13 14 … 37
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!